SUMMARY We report the case of a 29 year old woman with a protein losing enteropathy caused by systemic lupus erythematosus presenting with periorbital oedema. Only three other cases of protein losing enteropathy due to systemic lupus erythematosus have been described,' -3 two of which were thought to be because of a primary enteropathy,1 2 although the exact pathogenesis was unknown. We suggest that both the protein losing enteropathy and periorbital oedema in this patient were because of increased capillary permeability to serum albumin, as a result of products of plasma C3 conversion which were present in large amounts. It is also of interest that the antigen/antibody system in this patient was RNP/anti-RNP and that DNA antibodies were not detected. This patient falls into a subset of systemic lupus erythematosus in which anti-DNA antibodies are not present, some of which appear to have a more favourable prognosis.
A 29 year old white woman presented to the dermatology clinic with a history of intermittent periorbital oedema for one year after a holiday in New Zealand, and ankle oedema for three weeks. Further enquiry revealed general malaise and lassitude for several months, Raynaud's phenomenon for two years and secondary infertility of unknown cause for the past eight years. She had been investigated five years previously for polyarthritis at which time the ESR was 28, rheumatoid factor was negative and ANF was positive at a titre of 1 in 60. Since then, she had had mild intermittent episodes of arthralgia in the elbows and the knees and had noticed a mild diffuse alopecia. There was no other relevant personal or family history and she was receiving no medication.
Clinical examination revealed symmetrical pernoribital and conjunctival oedema with bilateral pitting ankle oedema and her blood pressure was 95/60. No other abnormalities were found.
INVESTIGATIONS
The following investigations were normal: haemo-ECG. A 24 hour urine collection showed no protein and no growth was obtained from an MSSU.
The ESR was 114 mm/h (Westergren), blood urea 2 2 mmol/l (normal 3-3-8 3) and serum cholesterol raised at 10 0 mmol/l (normal 3.8-7.0). The 
Discussion
To our knowledge protein losing enteropathy with systemic lupus erythematosus has previously been described in only three patients. Two of these were thought to have a primary enteropathy, the pathogenesis of which was unknown' 2 and the other was secondary to constrictive pericarditis.3 Though various gastrointestinal manifestations of systemic lupus erythematosus have been described, including mesenteric vasculitis with intestinal infarction, ulceration and perforation, gastric atony, small bowel ileus and ulcerative colitis,5 none of these were present in this patient.
It is well known that oedema may occur at presentation or intermittently in patients with connective tissue diseases. Indeed, increased vascular permeability to albumin has been shown in such cases and is thought to be responsible. 6 Increased vascular permeability resulting in tissue oedema has also been reported after plasma C3 conversion by some intravenous drugs.7 In view of the marked degree of plasma C3 conversion in this patient, it is interesting to speculate, therefore, that products of C3 conversion are similarly responsible for increased vascular permeability in the gut and the skin. Unfortunately, however, we did not measure 'capillary permeability' in our patient, and can therefore not exclude the possibility of the oedema being secondary to hypoalbuminaemia, with the primary event being a vasculitis of the gut resulting in protein losing enteropathy.
It is of interest that the nuclear antigen/antibody system in this patient is RNP/anti-RNP and that DNA antibodies were not detected. In the one other report of protein losing enteropathy with systemic lupus erythematosus in which serum DNA antibodies were measured no increase was found.2 Such subsets of systemic lupus erythematosus have been described in which anti-DNA antibodies are not present, many of which appear to have a more favourable response to treatment and better long term prognosis.4 Certainly our patient has responded well to systemic steroids, as did the other two cases of systemic lupus erythematosus with protein losing enteropathy, in whom treatment was eventually discontinued with no recurrence of signs or symptoms up to one year later.
Finally, this case further emphasises the fact that chronic or periodic oedema should be investigated with a view to an underlying connective tissue disease.
We are grateful to Dr R E Church for allowing us to report this case. 
